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Abstract
We have investigated the effect of the presence of 25 mol percent cholesterol on the interactions of the antimicrobial
peptide gramicidin S (GS) with phosphatidylcholine and phosphatidylethanolamine model membrane systems using a variety
of methods. Our circular dichroism spectroscopic measurements indicate that the incorporation of cholesterol into egg
phosphatidylcholine vesicles has no significant effect on the conformation of the GS molecule but that this peptide resides in
a range of intermediate polarity as compared to aqueous solution or an organic solvent. Our Fourier transform infrared
spectroscopic measurements confirm these findings and demonstrate that in both cholesterol-containing and cholesterol-free
dimyristoylphosphatidylcholine liquid-crystalline bilayers, GS is located in a region of intermediate polarity at the polar^
nonpolar interfacial region of the lipid bilayer. However, GS appears to be located in a more polar environment nearer the
bilayer surface when cholesterol is present. Our 31P-nuclear magnetic resonance studies demonstrate that the presence of
cholesterol markedly reduces the tendency of GS to induce the formation of inverted nonlamellar phases in model
membranes composed of an unsaturated phosphatidylethanolamine. Finally, fluorescence dye leakage experiments indicate
that cholesterol inhibits the GS-induced permeabilization of phosphatidylcholine vesicles. Thus in all respects the presence of
cholesterol attenuates but does not abolish the interactions of GS with, and the characteristic effects of GS on, phospholipid
bilayers. These findings may explain why it is more potent at disrupting cholesterol-free bacterial than cholesterol-containing
eukaryotic membranes while nevertheless disrupting the integrity of the latter at higher peptide concentrations. This
additional example of the lipid specificity of GS may aid in the rational design of GS analogs with increased antibacterial but
reduced hemolytic activities. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Gramicidin S (GS) is a cyclic decapeptide of pri-
mary structure (cyclo-(Val-Orn-Leu-D-Phe-Pro)2) se-
creted by Bacillus brevis. It is a powerful antimicro-
bial agent with potent cidal action on a wide variety
of Gram-negative and Gram-positive bacteria as well
as on several pathogenic fungi. Unfortunately, how-
ever, GS is rather non-speci¢c in its actions and also
exhibits a relatively high hemolytic activity, limiting
its use as an antibiotic to topical applications. The
GS molecule exists as a very stable amphiphilic anti-
parallel L-sheet structure in a wide variety of envi-
ronments, with a polar and a non-polar surface (see
Fig. 1). Moreover, the large number of structure^
activity studies of GS analogs which have been car-
ried out indicate that this ‘sidedness’ structure is re-
quired for its antimicrobial action (for reviews, see
[1^3]). There is good evidence from studies of the
interaction of GS with bacterial cells that the de-
struction of the integrity of the lipid bilayer of the
inner membrane is the primary mode of the antimi-
crobial action of this peptide. Moreover, GS parti-
tions strongly into liquid-crystalline lipid bilayers in
both model and biological membranes and seems to
be located primarily in the glycerol backbone region
below the polar headgroups and above the hydro-
carbon chains. GS also binds more strongly to
anionic than to zwitterionic or uncharged phospho-
and glycolipids. The presence of GS appears to per-
turb lipid packing in liquid-crystalline bilayers and
GS can induce the formation of inverted cubic
phases at lower temperatures in lipids capable of
forming such phases at higher temperature in the
absence of peptide. The presence of GS at lower
concentrations also increases the permeability of
model and biological membranes and at higher con-
centrations causes membrane destabilization (see
[1^3]). The considerable lipid speci¢city of GS for
binding to and destabilization of lipid bilayer model
membranes indicates that the design of GS analogs
with an improved antimicrobial potency and a mark-
edly decreased toxicity for eukaryotic cell plasma
membranes should be possible (see [1^5])
A major di¡erence between the lipid compositions
of bacterial and animal cell surface membranes is the
presence of cholesterol in the latter but not in the
former membrane systems [6,7]. In fact, cholesterol
is a major component of animal cell plasma mem-
branes, comprising up to almost 50 mol percent of
the total membrane lipid. However, although a num-
ber of biophysical studies of the interactions of GS
with phospholipid model membranes have been car-
ried out, none of these previous studies have ad-
dressed the e¡ect of the presence of cholesterol on
the nature and strength on GS^phospholipid interac-
tions (see [1^3]). In order to rectify this situation, we
have carried out the present study with the goal of
determining the e¡ect of cholesterol on the binding
and penetration of GS into phosphatidylcholine (PC)
bilayers and on the ability of GS to induce inverted
nonlamellar phases in phosphatidylethanolamine dis-
persions. We have also investigated the e¡ect of cho-
lesterol on the ability of GS to permeabilize lipo-
somes composed of PC. In all cases the presence of
cholesterol was found to attenuate the characteristic
e¡ects of GS on the target phospholipid model mem-
brane.
Fig. 1. Structure and conformation of GS. (Upper panel) Top
view of the backbone structure of GS indicating the positions
of the L-sheet interstrand hydrogen bonds. (Lower panel) Side
view of GS indicating the disposition of the hydrophobic (top)
and basic (bottom) residues relative to the peptide ring.
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2. Materials and methods
Phospholipids and cholesterol were obtained from
Avanti Polar Lipids Inc. (Alabaster, AL, USA) and
used without further puri¢cation. Calcein was sup-
plied by Molecular Probes (Eugene, OR, USA). GS
was obtained from Sigma (St. Louis, MO, USA) and
puri¢ed using the methodology described by Konde-
jewski et al. [4]. The peptide was subsequently con-
verted to the hydrochloride salt by two cycles of ly-
ophilization from 10 mM hydrochloric acid in order
to remove the tri£uoroacetate (TFA) counter ions
which interfere with the monitoring of the phospho-
lipid CNO stretching vibrations by Fourier trans-
form infrared (FTIR) spectroscopy.
To prepare GS-containing large multilamellar
vesicles (MLVs), the appropriate phospholipid or
phospholipid/cholesterol mixture was co-dissolved
in methanol with GS and the solvent was removed
by slow evaporation under nitrogen such that the
lipid/peptide mixture would be deposited as a thin
¢lm in a clean glass test tube. Subsequently, the
last traces of solvent were removed by overnight
evacuation and the samples hydrated with appropri-
ate bu¡er by vigorous vortexing at temperatures well
above the gel/liquid crystalline phase transition tem-
perature of the phospholipid or phospholipid/choles-
terol mixtures. For the circular dichroism (CD) ex-
periments, small unilamellar vesicle (SUVs) were
prepared from large MLVs by sonication with a
probe sonicator for 15^20 min, followed by centrifu-
gation for 20 min at 14 000Ug to remove titanium
particles.
CD spectra were measured on a Jasco 720 spec-
tropolarimeter (Tokyo, Japan). Ellipticities are re-
ported as the mean residue ellipticity (a) of GS. Spec-
tra were measured in bu¡er solutions (100 WM
peptide) composed of ¢nal concentrations of Tris
(10 mM), NaF (150 mM) and EDTA (0.1 mM) at
pH 7.4. All of the measurements were in quartz cells
with 0.1 cm pathlength at 25‡C. The total lipid con-
centration was 1 mM. Peptide concentrations be-
tween 10 and 100 WM did not reveal major di¡er-
ences in the shape of the spectra.
FTIR spectra were recorded with a Digilab FTS-
40 Fourier transform instrument (Digilab, Cam-
bridge, MA, USA) using procedures for sample prep-
aration, data acquisition and subsequent data pro-
cessing similar to those previously used in this
laboratory [8]. Samples for such experiments were
prepared by dispersing 2^3 mg of lipid (or lipid/pep-
tide) material in 50 Wl of a D2O-based bu¡er com-
posed of 50 mM phosphate, 100 mM NaCl, 1 mM
NaN3, pH 7.4.
31P-nuclear magnetic resonance (NMR) spectra
were recorded with a Varian Unit-300 instrument
(Varian Instruments, Palo Alto, CA, USA) operating
at 124.42 MHz for 31P. The sample preparation
methodology and data acquisition and analysis
were the same as previously used in this laboratory
[9]. Lipid and lipid/peptide samples were dispersed in
50 mM Tris, 100 mM NaCl, 1 mM NaN3, 5 mM
EDTA, pH 7.4.
For the £uorescence dye leakage experiments, cal-
cein was dissolved in the same Tris bu¡er used for
the 31P-NMR experiments at self-quenching concen-
trations (70 mM). The lipid or lipid/peptide mixture
was dried as described above and hydrated with the
Calcein-containing Tris bu¡er. After 4 or 5 freeze/
thaw cycles, large unilamellar vesicles (LUVs) were
prepared by extrusion through 200 nm ¢lters (ex-
truder and ¢lters were obtained from Avestin, Otta-
wa, Ont., Canada). Excess dye was removed on pre-
packed columns of PD-10 containing Sephadex G-
25M (Amersham Pharmacia, Baie d’Urfe¤, Que., Can-
ada) and the lipid content determined according to
Broekhuyse [10]. Calcein leakage experiments were
recorded with a Perkin Elmer LS-50B spectro-
£uorimeter (Beacons¢eld, UK). The excitation wave-
length was 496 nm, the emission was 517 nm and slit
widths of 5 nm were used. The temperature (37‡C)
was controlled by an external waterbath (Neslab,
Portsmouth, NH, USA).
3. Results
The CD spectra of GS dissolved in aqueous bu¡er
or tri£uoroethanol (TFE)/H2O (1:1, v/v), or incorpo-
rated into SUV’s of egg PC or egg PC/Cholesterol
(4:1) mol ratio), are presented in Fig. 2. The CD
spectrum in aqueous bu¡er exhibits two minima at
208 and 217 nm of almost comparable molar ellip-
ticity. In TFE/H2O, the overall shape of the CD
spectrum of GS is maintained, but the two minima
in the molar ellipticity values are shifted to shorter
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wavelengths, the ratio of the ellipticity minimum at
the shorter to that of the longer wavelength in-
creases, and the molar ellipticity curve in general is
shifted to more negative values. The CD spectra of
GS incorporated into egg PC or egg PC/cholesterol
SUV’s exhibits behavior intermediate between that in
bu¡ered H2O and TFE/H2O, although the cholester-
ol-containing vesicles exhibit an ellipticity minimum
at slightly higher wavelength and the spectrum as a
whole is slightly less negative. Although a more de-
tailed interpretation of these results will be given in
Section 4, for now we simply note these CD spectra
indicate that the characteristic L-sheet/L-turn confor-
mation of GS is maintained in environments of
widely di¡erent polarity and hydrogen-bonding po-
tential, in agreement with extensive previous work
(see [1^3]) and with the FTIR spectroscopic results
presented previously [11] and below.
A large number of studies have established that
the characteristic conformation of the GS molecule
is maintained in water, in protic and aprotic solvents
of widely varying polarity, and in detergent micelles
and phospholipid bilayers, over a wide range of tem-
perature (see [1^3]). We have recently taken advan-
tage of the conformational invariance of this peptide
to relate changes in the frequency of the infrared
amide I absorption band of the L-sheet region of
the GS molecule exclusively to the polarity and hy-
drogen-bonding potential of its environment, since
such frequency changes should not arise from alter-
ations in the secondary or tertiary structure of the
GS molecule itself. This approach has permitted us
to determine the degree of association of the GS
molecule with the gel and liquid-crystalline states of
phospho- and glycolipid bilayers and their location
in such model membrane systems [11]. We apply
the same approach here to determine the e¡ect of
the presence of cholesterol on the interaction of GS
with dimyristoylphosphatidylcholine (DMPC) MLVs
above and below their gel/liquid-crystalline phase
transition temperatures.
The CNO stretching absorption band of the phos-
pholipid molecules and the amide 1 absorption band
of the GS molecules, at temperatures below (0‡C)
and above (50‡C) the gel/liquid-crystalline phase
transition temperature range of DMPC MLVs with
or without 25 mol percent cholesterol, are shown in
Fig. 3. In DMPC MLVs, the broad amide I absorp-
tion centered at 1638 cm31 in the gel state consists of
two components centered near 1628 and 1646 cm31,
while in the liquid-crystalline state, the overall center
Fig. 3. FTIR spectra showing the CNO stretching and amide I
bands of cholesterol-free (A) and cholesterol-containing (B)
DMPC liposomes. The upper traces show spectra acquired at
temperatures below the onset of the lipid hydrocarbon chain-
melting phase transition (0‡C) whereas the lower traces show
spectra acquired at temperatures above the completion of the
lipid hydrocarbon chain-melting phase transition (50‡C). GS-
containing samples were prepared at lipid:peptide ratios of 25:1
and the cholesterol-rich lipid samples contained 25 mol percent
cholesterol. The dotted lines represent the single components
that could be resolved in the peaks.
Fig. 2. CD spectra for GS dissolved in aqueous bu¡er (-O-O-)
or TFE:H2O (1:1, by volume) (-P-P-) or associated with egg
PC SUVs containing (-E-E-) or not containing (-a-a-) 20 mol
percent cholesterol. The total lipid concentration is 1 mM.
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of gravity of the now sharper amide I band shifts to
a frequency near 1645 cm31 and is not obviously
multicomponent. We have shown previously that
the upward shift in amide I band frequency with
temperature is due to a decrease in environmental
polarity resulting from the increased penetration of
GS molecules into the interfacial region of DMPC
bilayers in the liquid-crystalline state, and that the
amide I band component at 1628 cm31 observed in
the gel state arises from GS molecules in a relatively
polar environment, either in the aqueous phase or at
the bilayer surface [11]. Although a generally similar
behavior is noted in the DMPC/cholesterol MLVs, at
both low and high temperatures the frequency of the
GS amide I band is lower than that observed in the
cholesterol-free DMPC MLVs. In fact, at 0‡C, the
GS amide I band frequency of 1626 cm31 in the
DMPC/cholesterol MLVs is similar to that observed
for GS dissolved in D2O-based bu¡er [11]. These
results indicate that in the gel state, cholesterol pro-
motes the exclusion of the GS molecules from the
DMPC bilayer and that in the liquid-crystalline state,
the GS molecules on average reside in an environ-
ment of lower polarity, indicating less extensive pen-
etration of the GS molecules into DMPC bilayers in
the presence of cholesterol.
The 31P-NMR spectra shown in Fig. 4 illustrate
the e¡ect of GS on the thermotropic phase behav-
ior of cholesterol-free and cholesterol-containing
dipalmitelaidoylphosphatidylethanolamine (DPEPE)
membranes. In the absence of GS, cholesterol-free
DPEPE preparations exhibit 31P-NMR powder pat-
terns consistent with their phosphate moieties under-
going fast axially symmetric motion in liquid-crystal-
line bilayers at all temperatures between 25 and
75‡C. This result is consistent with the known phase
behavior of DPEPE, which exhibits a LL/LK phase
transition at temperatures near 21‡C and a LK/HII
phase transition at temperatures near 92‡C [12].
The incorporation of GS into these cholesterol-free
membranes has two major e¡ects on the 31P-NMR
spectra observed. First, like the peptide-free sample,
the 31P-NMR powder patterns observed at temper-
atures of 40‡C and below are indicative of the
DPEPE forming predominantly a lamellar liquid-
crystalline phase. However, in these spectra the in-
tensity of all down¢eld components are markedly
reduced relative to what is observed with DPEPE
alone. This pattern of behavior was observed in pre-
vious 31P-NMR studies of GS-phospholipid interac-
tions [9] and is consistent with the idea that GS
makes phospholipid vesicles more susceptible to
magnetically induced sample orientation under our
conditions (for more details, see [9] and references
therein). Second, the incorporation of GS into this
DPEPE dispersion causes a marked reduction in the
high-temperature stability of the lamellar liquid-crys-
talline phase, since at temperatures above 40‡C the
bilayer powder patterns are progressively replaced by
an isotropic peak at higher temperatures. This pat-
tern of behavior has been ascribed to the GS-induced
formation of inverted cubic phases in these DPEPE
dispersions [9] and in dispersions of the total mem-
brane lipids from Escherichia coli [13]. Available data
Fig. 4. Proton decoupled 31P-NMR spectra showing the e¡ect
of GS on cholesterol-free (top panel) and cholesterol-containing
(bottom panel) DPEPE liposomes. The data presented were ac-
quired in the heating mode at the temperatures indicated. The
data acquired with the peptide-free samples are located on the
left and those observed with the peptide-containing samples
(lipid:peptide ratio = 25:1) are located on the right.
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suggest that the capacity of GS to induce cubic phase
formation in lipid bilayers is a function of the intrin-
sic nonlamellar-forming tendencies of the host lipid
and may also be a key to the hemolytic and antimi-
crobial activities of this peptide [9,13].
The results presented in Fig. 4 also show that the
incorporation of cholesterol itself into DPEPE mem-
branes markedly enhances the propensity of those
membranes to form inverted nonlamellar structures.
As noted above, lipid bilayers composed of pure
DPEPE exhibit a LK/HII phase transition at temper-
atures near 92‡C [12]. However, DPEPE dispersions
containing 25 mol percent cholesterol exhibit 31P-
NMR powder patterns consistent with the formation
of lamellar phases at temperatures only up to 55‡C
and powder patterns consistent with the formation of
inverted hexagonal phases at temperatures of 70‡C.
A cholesterol-induced increase in inverted phase-
forming propensity has been observed previously
with other PE bilayers [14^17]. Fig. 4 shows that
GS also a¡ects the phase preferences of the choles-
terol-containing DPEPE dispersion, as shown by the
appearance of a small isotropic peak beginning at
temperatures near 55‡C, which grows in intensity
and predominates at temperatures above 70‡C. As
noted above, the appearance of an isotropic peak
in the 31P-NMR spectra of GS-containing phospho-
lipid dispersions has been ascribed to the GS-induced
formation of an inverted cubic phase. Thus, choles-
terol-free DPEPE membranes are more susceptible to
GS-induced cubic phase formation than are the cor-
responding cholesterol-containing preparations.
Moreover, GS-containing cholesterol-free prepara-
tions are more susceptible to magnetically induced
sample orientation than are the corresponding cho-
lesterol-containing samples (see spectra acquired at
T9 40‡C in Fig. 4). In particular, the loss of inten-
sity in the down¢eld components of the axially sym-
metric powder patterns is more pronounced with the
cholesterol-free GS-containing than with cholesterol-
containing DPEPE dispersions. Together, these dif-
ferences between the e¡ects of GS on the cholesterol-
free and cholesterol-containing DPEPE membranes
provide strong evidence for a cholesterol-mediated
attenuation of GS e¡ects on the inverted nonlamellar
phase-forming propensity of these phospholipid bi-
layers.
After studying the membrane interaction and po-
tential structural changes in the lipid bilayers induced
by GS, we wished to investigate if any of the spec-
troscopically detectable di¡erences in the e¡ects of
GS on cholesterol-containing and cholesterol-free
model membranes are relevant to the actual mem-
brane-disruptive potential of this peptide. We thus
performed dye release experiments and induced cal-
cein leakage from LUVs of cholesterol-free and cho-
lesterol-containing 1-palmitoyl,2-oleoyl-phosphati-
dylcholine (POPC) at lipid-to-peptide ratios of
25:1. As shown in Fig. 5, the cholesterol-free and
cholesterol-containing samples are both susceptible
to GS-induced calcein leakage under those condi-
tions, but the relative amount of calcein released
from the cholesterol-free vesicles signi¢cantly exceeds
that released from the corresponding cholesterol-con-
taining sample. Indeed, we generally ¢nd cholesterol-
containing POPC vesicles are consistently more resis-
tant to GS-induced leakage than are the correspond-
ing cholesterol-free vesicles under all conditions
where measurable amounts of GS-induced leakage
occurs. This indicates that the susceptibility of lipid
membranes to GS-induced disruption is also attenu-
ated by the presence of signi¢cant amounts of cho-
lesterol.
Fig. 5. GS-induced calcein leakage from POPC LUVs (25 WM
lipid) in the absence and presence of cholesterol (25 mol per-
cent) and a lipid:peptide ratio of 25:1 (mol/mol) is shown as a
function of time. Maximum dye release was induced by adding
100 Wl of Triton X-100 (1%) to completely lyse the LUVs.
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4. Discussion
The CD spectrum of GS dissolved in a relatively
less polar but hydrogen-bond forming organic sol-
vent such as TFE results in an overall enhancement
of molar ellipticity, an increase in the ratio of the
molar ellipticity of the lower frequency minimum rel-
ative to the higher frequency minimum, and a shift
of the ellipticity minima to lower frequencies as com-
pared to H2O, while the values in egg PC and egg
PC/cholesterol SUV’s are intermediate. However, the
overall shapes of the CD spectra exhibited by GS in
aqueous bu¡er, in egg PC or egg PC/cholesterol
SUV’s, or in TFE/H2O (1:1, v/v) are generally sim-
ilar, indicating that this molecule retains its overall
L-sheet/L-turn conformation in all four systems, as
expected from previous work con¢rming the relative
conformational invariance of this peptide in a variety
of environments (see [1^3]). However, the increase
in the ratio of the molar ellipticity of the lower
frequency minima to the higher frequency minima
and the overall increase in the negative ellipticity
values as one proceeds from aqueous bu¡er to
TFE may re£ect a minor conformational change,
possibly a slight alteration in the twist of the anti-
parallel L-sheet backbone [18]. Alternatively, these
spectral changes may result from an increase in the
conformational rigidity of the GS molecule, due
to an enhancement of intramolecular hydrogen
bonding in the molecule in the less polar, less
strongly hydrogen bonding environment of TFE.
Alcohols of relatively lower polarity such as TFE
are believed to be less e¡ective than H2O in their
ability to form hydrogen bonds with the carbonyl
and amide groups of the peptide backbone, thus in-
creasing the strength of intramolecular hydrogen
bonding and the stability and rigidity of secondary
structures in general [19,20]. Moreover, the blue shift
in the two minima in the CD spectra observed in
going from water to TFE is expected due to a de-
crease in the polarity of the environment of the
GS molecule [18]. Interestingly, the blue shifts in
the CD spectra of GS in egg PC or egg PC/choles-
terol SUV’s are intermediate between those of
water and TFA. This result is compatible with our
previous FTIR study, which indicated that GS re-
sides in an environment of intermediate polarity in
liquid-crystalline PC bilayers, such as occurs at the
glycerol backbone region of the phospholipid mole-
cule [11].
Our present FTIR study of the e¡ect of cholesterol
on the interactions of GS with DMPC MLVs indi-
cate that the polarity of the environment of the pep-
tide molecule in cholesterol-containing DMPC bi-
layers in the biologically relevant liquid-crystalline
state is higher than that of cholesterol-free DMPC
bilayers, as shown by the lower frequency of the GS
amide I absorption band (1640 cm31 versus 1645
cm31, respectively). Since cholesterol is known to
condense and order liquid-crystalline phospholipid
bilayers (see [21]), this ¢nding is consistent with the
results of our previous calorimetric [22] and FTIR
[11] spectroscopic studies, which indicate that GS
interacts more strongly with, and penetrates more
deeply into, more £uid bilayers. However, the
present FTIR spectroscopic data suggest that the
presence of cholesterol actually results in a greater
exclusion of GS molecules in gel state DMPC bi-
layers as well, which is not expected, since cholesterol
is well known to expand and disorder phospholipid
bilayers in the gel state (see [7,21]). It is possible that
the rigid fused ring system of the cholesterol mole-
cule, and the more hydrophobic and less hydrated
interface between the polar headgroups and the hy-
drophobic fatty acyl chains in the phospholipid bi-
layer produced by this sterol, may hinder the inser-
tion of GS molecules, even though cholesterol has an
overall net disordering e¡ect on gel-phase DMPC
bilayer. Clearly additional experimental work, possi-
bly employing various cholesterol analogs, will be
required to resolve this issue.
Our 31P-NMR spectroscopic data show that GS-
induced cubic phase formation is initiated at lower
temperatures in cholesterol-free DPEPE dispersions
than in the corresponding cholesterol-containing sys-
tem, indicating that the presence of cholesterol mark-
edly reduces the susceptibility of the DPEPE bilayer
to the potentially disruptive e¡ects of GS interaction.
This observation is particularly notable because the
cholesterol-induced attenuation of GS-mediated in-
verted cubic phase formation occurs despite the
fact that cholesterol itself markedly promotes HII
phase formation in DPEPE dispersions in the ab-
sence of peptide. Since the ability of GS to induce
inverted nonlamellar phases in model membranes
composed of the total membrane lipids from bacteria
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has been demonstrated previously and may be an
important aspect of the membrane lytic ability of
this peptide [9,13], this result is a potentially impor-
tant one.
The results of our present spectroscopic studies
indicate that the presence of cholesterol attenuates
the interaction of GS with PC bilayers and the pro-
pensity of this peptide to induce inverted nonlamellar
phases in PE bilayers. Moreover, the results of our
calcein leakage experiments indicate that these e¡ects
are also manifest in the ability of this peptide to
induce lipid bilayer membrane permeabilization or
lysis, since cholesterol-containing POPC LUVs are
more resistant to GS-induced permeabilization than
are cholesterol-free POPC LUVs. The present results
support an earlier report which indicated that the
addition of cholesterol (amount unspeci¢ed) to egg
PC LUVs decreased the rate of K leakage by about
25% when GS was added at a phospholipid/peptide
ratio of 125:1 [23]. Note, however, that although the
presence of 25 mol percent cholesterol decreases the
rate of calcein leakage by about half in POPC LUVs,
these model membranes are nevertheless still permea-
bilized by GS at a phospholipid/peptide ratio of 25:1
and can be completely lysed at higher peptide con-
centrations. This ¢nding is compatible with the ac-
tion of GS on natural membranes, where previous
studies have shown that this peptide will disrupt
both cholesterol-containing eukaryotic plasma mem-
branes and cholesterol-free bacterial inner mem-
branes but is more e¡ective against the latter (see
[1,2]). In this regard it is interesting to note that in
general, the actions of the antibacterial peptides syn-
thesized by higher organisms are inhibited by the
presence of cholesterol [24^28], in keeping with a
minimization of cell membrane damage to the host
animal by these agents. In contrast, the actions of the
membrane lytic protein toxins or macrolide antifun-
gal agents secreted by bacteria are generally not only
not inhibited by the presence of cholesterol, but this
sterol may even be a speci¢c target for the disruption
of the membrane lipid permeability barrier [29^32].
The fact that GS is relatively more potent against
cholesterol-free prokaryotic than against eukaryotic
cholesterol-containing membrane suggests that the
primary target of this bacterially synthesized antimi-
crobial peptide is competing bacterial species in its
natural environment.
The decreased sensitivity of cholesterol-containing
model and biological membranes to the action of GS
should aid us in our search for GS analogs with
increased antimicrobial activity and decreased hemo-
lytic activity, since we can, in principle, design GS
analogs whose interactions with cholesterol-contain-
ing phospholipid model membranes are diminished
with respect to the parent compound. However,
our previous calorimetric [22] and FTIR spectroscop-
ic [11] studies indicate that the strength of GS inter-
actions with various phospholipid bilayers increases
with the degree of negative charge and with the £uid-
ity of these model membranes, and our previous 31P-
NMR spectroscopic [9] and X-ray di¡raction studies
[13] also suggest that GS destabilizes lipid bilayers by
increasing the negative monolayer curvature of such
structures through interaction with inverted nonla-
mellar phase-forming phospho- and glycolipids. The
question of whether or not cholesterol exerts its at-
tenuating e¡ects on GS action through its e¡ects on
one or more of these three factors, or through an-
other mechanism, awaits further study. However, the
rational design of GS analogs with a higher thera-
peutic index must take into account the fact that GS
appears to interact with model and biological mem-
branes in complex, multifaceted ways.
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